The BCG World Atlas: a database of global BCG vaccination policies and practices

Alice Zwerling, Marcel A Behr, Aman Verma, Timothy F Brewer, Dick Menzies, Madhukar Pai, Alice Zwerling, Marcel A Behr, Aman Verma, Timothy F Brewer, Dick Menzies, Madhukar Pai

Abstract

Madhu Pai and colleagues introduce the BCG World Atlas, an open access, user friendly Web site for TB clinicians to discern global BCG vaccination policies and practices and improve the care of their patients.

Conflict of interest statement

No financial conflicts. Madhukar Pai serves as an external consultant for the Bill & Melinda Gates Foundation (BMGF). BMGF had no involvement in this manuscript. Madhukar Pai is a member of the PLoS Medicine Editorial Board.

Figures

Figure 1. Home page of the BCG…
Figure 1. Home page of the BCG World Atlas (http://www.bcgatlas.org/) and example of BCG policies and practices in Japan.
Figure 2. Map displaying BCG vaccination policy…
Figure 2. Map displaying BCG vaccination policy by country.
A: The country currently has universal BCG vaccination program. B: The country used to recommend BCG vaccination for everyone, but currently does not. C: The country never had universal BCG vaccination programs.
Figure 3. Countries most likely to benefit…
Figure 3. Countries most likely to benefit from highly specific IGRAs for the diagnosis of LTBI.
One of the applications of this database is its ability to identify populations where repeated BCG immunizations were administered or where BCG was administered after infancy, as these populations are most likely to benefit from the use of highly specific IGRAs for the diagnosis of LTBI.

References

    1. World Health Organization [WHO] WHO global tuberculosis control: WHO report 2010. Geneva: World Health Organization; 2010.
    1. Centers for Disease Control and Prevention [CDC] Reported tuberculosis in the United States, 2008. Atlanta: CDC; 2009.
    1. CDC. 2010. Reported tuberculosis in the United States 2009.
    1. Ellis E, Dawson K, Gallant V, Scholten D. Tuberculosis in Canada: 2008 pre-release. Ottawa: Public Health Agency of Canada; 2009.
    1. Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med. 1931;24:1481–1490.
    1. Greenwood M. Professor Calmette's statistical study of B.C.G. vaccination. Br Med J. 1928;1:793–795.
    1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994;271:698–702.
    1. Brewer TF, Wilson ME, Nardell EA. BCG immunization: review of past experience, current use, and future prospects. Curr Clin Top Infect Dis. 1995;15:253–270.
    1. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999;284:1520–1523.
    1. Behr MA. BCG–different strains, different vaccines? Lancet Infect Dis. 2002;2:86–92.
    1. Brewer TF, Colditz GA. Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis. 1995;20:126–135.
    1. Ritz N, Curtis N. Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb) 2009;89:248–251.
    1. WHO. WHO Statistical Information System (WHOSIS) Geneva: WHO; 2007.
    1. Koch R. Weitere Mitteilungen uber ein Heilmittel gegen Tuberculose. Dtsch Med Wschr. 1891;17:101–102.
    1. Wallis R, Pai M, Menzies D, Doherty T, Walzl G, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375:1920–1937.
    1. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168–1173.
    1. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 2001;286:1740–1747.
    1. Stop TB Partnership Working Group on New TB Vaccines. 2009. Tuberculosis vaccine candidates - 2009.
    1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–184.
    1. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med. 2009;30:701–716, viii.
    1. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192–1204.
    1. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–354.
    1. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. Eur Respir J. 2011;37:88–99.
    1. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology. 2007;12:88–92.
    1. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006;27:442–448.
    1. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri SP, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-g assay with tuberculin skin testing. JAMA. 2005;293:2746–2755.
    1. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174:349–355.
    1. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13:84–92.
    1. WHO. WHO global TB report. Geneva: World Health Organization; 2009.
    1. Nakamura RM, Velmonte MA, Kawajiri K, Ang CF, Frias RA, et al. MPB64 mycobacterial antigen: a new skin-test reagent through patch method for rapid diagnosis of active tuberculosis. Int J Tuberc Lung Dis. 1998;2:541–546.
    1. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax. 2007;62:911–918.
    1. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 2007;4:e202. doi: .
    1. Stop TB Partnership. The Global Plan to Stop TB, 2006–2015. Actions for life: towards a world free of tuberculosis. Int J Tuberc Lung Dis. 2006;10:240–241.
    1. WHO. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec. 2007;82:193.
    1. International Union Against Tuberculosis and Lung Disease [IUATLD] Consensus IUATLD statement on the revised world health organization recommendations regarding BCG vaccination in HIV-infected infants. Paris: IUATLD; 2008.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi